Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection.

QIAGEN N.V.’s (QGEN - Free Report) first-quarter 2025 adjusted earnings per share (EPS) were 55 cents, and 56 cents at ...

Diagnostic solutions registered the highest growth, driven by strong demand for QuantiFERON and QIAstat-Dx. PCR/Nucleic acid amplification technologies also posted solid growth, supported by the ...

The aim of the present work was to evaluate the usefulness of the interferon-gamma release assays (IGRAs): QuantiFERON-tuberculosis (TB) Gold-In-Tube test (QFG) and T-SPOT.TB for the diagnosis of ...